Get the Stockscreener App
1.41
2.76%
-0.04
After Hours:
1.41
Abvc Biopharma Inc stock is traded at $1.41, with a volume of 17,419.
It is down -2.76% in the last 24 hours and down -11.88% over the past month.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$1.45
Open:
$1.52
24h Volume:
17,419
Relative Volume:
0.27
Market Cap:
$34.26M
Revenue:
$797.90K
Net Income/Loss:
$-4.44M
P/E Ratio:
-6.3172
EPS:
-0.2232
Net Cash Flow:
$-1.82M
1W Performance:
+9.30%
1M Performance:
-11.88%
6M Performance:
-46.79%
1Y Performance:
+120.04%
1-Day Range:
$1.38
$1.52
1-Week Range:
$1.18
$1.6744
52-Week Range:
$0.61
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Name
Abvc Biopharma Inc
Sector
Industry
Phone
510-668-0881
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
1.41 | 35.24M | 797.90K | -4.44M | -1.82M | -0.2232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Abvc Biopharma Inc Stock (ABVC) Latest News
ABVC BioPharma Reports 179% Asset Growth in 2025, Shifts Toward Hybrid Business Model - citybuzz -
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), ABVC BioPharma, Inc. has identified significant deficiencies in its internal control over financial reporting for the fiscal year 2025. - Bitget
ABVC BioPharma Reports 2025 Form 10-K - Yahoo Finance
ABVC BioPharmaquarterly period ended September, 2025 financial statements should not be relied upon - marketscreener.com
ABVC BioPharma (ABVC) restates Q3 2025 results and warns on going concern - Stock Titan
ABVC BioPharma (NASDAQ: ABVC) details biotech pipeline, risks and listing - Stock Titan
Restatement and asset surge reshape ABVC BioPharma (NASDAQ: ABVC) - Stock Titan
Sentiment Review: Should I buy ABVC BioPharma Inc stock nowJuly 2025 Setups & Verified Chart Pattern Signals - baoquankhu1.vn
Can ABVC BioPharma Inc lead its sector in growthPortfolio Value Report & AI Enhanced Trading Signals - baoquankhu1.vn
ABVC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ABVC BioPharma Establishes BioKey Cayman Subsidiary as Part of Commercialization Strategy - citybuzz -
ABVC BioPharma Provides Corporate and Structural Update - Yahoo Finance
Tech Rally: Does ABVC BioPharma Inc have high return on assetsTrend Reversal & Daily Price Action Insights - baoquankhu1.vn
ABVC Should I Buy - Intellectia AI
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Declines By 26.8% - Defense World
Why ABVC BioPharma Inc. stock is a must watch in 2025Weekly Investment Report & Community Driven Trade Alerts - mfd.ru
ABVC Biopharma Inc. Announces Date for Upcoming Annual Shareholder Meeting - Longbridge
How ABVC BioPharma Inc. stock performs during Fed tightening cyclesPortfolio Growth Summary & Weekly Watchlist of Top Performers - mfd.ru
Is ABVC BioPharma Inc. forming a breakout patternJuly 2025 Selloffs & Safe Entry Point Alerts - mfd.ru
Activity Recap: Is CGNX showing insider buyingInflation Watch & Fast Moving Market Watchlists - baoquankhu1.vn
Aug Momentum: What are FEIMs technical support levelsTrade Volume Report & Risk Managed Investment Signals - baoquankhu1.vn
Is ABVC BioPharma Inc. in a consolidation phaseMarket Insider Reports & Small Investment Trading Tips - bollywoodhelpline.com
Plus Therapeutics Prices Public Offering, Raising $15 Million - Intellectia AI
Recap Report: Can Akso Health Group Depositary Receipt outperform under higher oil prices2025 Key Highlights & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Sentiment Watch: Will ABVC BioPharma Inc stock deliver shareholder valueMarket Growth Report & High Accuracy Investment Signals - Bộ Nội Vụ
Aug Swings: Is ABVC BioPharma Inc stock good for income investorsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Update Recap: Is ABVC BioPharma Inc part of any major indexTrade Risk Summary & Capital Protection Trading Alerts - baoquankhu1.vn
Is ABVC BioPharma Inc. stock oversold or undervaluedEarnings Recap Report & Accurate Buy Signal Alerts - Улправда
Will ABVC BioPharma Inc. stock pay special dividends2025 Macro Impact & Weekly High Return Stock Forecasts - Улправда
Can ABVC BioPharma Inc. stock hit analyst price targetsJuly 2025 Review & Safe Capital Growth Tips - Улправда
What momentum indicators show for ABVC BioPharma Inc. stock2026 world cup usa national team quarterfinals star players transition play group prediction analysis - Улправда
ABVC BioPharma (NASDAQ:ABVC) Trading Down 4.9%Here's What Happened - MarketBeat
ABVC BioPharma (NASDAQ:ABVC) Trading Down 4.9% – Here’s What Happened - Defense World
Would You Still Hold ABVC BioPharma Stock If It Fell Another 30%? - Trefis
ABVC BioPharma Earnings Notes - Trefis
How ABVC BioPharma Inc. stock reacts to inflationary pressuresProfit Target & Long Hold Capital Preservation Plans - Улправда
Trading Recap: How ABVC BioPharma Inc. stock reacts to inflationary pressuresWeekly Risk Summary & Fast Entry and Exit Trade Plans - Улправда
Analyzing ABVC BioPharma (NASDAQ:ABVC) & Oculis (NASDAQ:OCS) - Defense World
Head-To-Head Analysis: ABVC BioPharma (NASDAQ:ABVC) & Northwest Biotherapeutics (OTCMKTS:NWBO) - Defense World
Can ABVC BioPharma Inc. stock beat market expectations this quarterEarnings Growth Report & Trade Opportunity Analysis Reports - Newser
ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States - TradingView
What analyst consensus says on ABVC BioPharma Inc. stockJuly 2025 Price Swings & AI Powered Market Trend Analysis - Newser
What margin trends mean for ABVC BioPharma Inc. stockPortfolio Value Summary & Long-Term Growth Plans - Newser
Upcoming Events - FinancialContent
ABVC BioPharma Highlights Strengthened Operations at BioKey's 28,176-sq.-ft. Silicon Valley Facility, Featuring U.S.-Based Multi-Product Capabilities Including Functional Foods, and Expansion Outlook Supporting Up to [1,000] Jobs by 2030 - TradingView
ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received - Yahoo Finance
Is ABVC BioPharma Inc. stock cheap compared to fundamentals2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Can ABVC BioPharma Inc. rally from current levelsInsider Selling & Precise Buy Zone Tips - newser.com
How geopolitical tensions affect ABVC BioPharma Inc. stockSell Signal & AI Enhanced Trading Signals - newser.com
Will earnings trigger a reversal in ABVC BioPharma Inc.Trend Reversal & AI Forecast Swing Trade Picks - newser.com
Will ABVC BioPharma Inc. price bounce be sustainableSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Abvc Biopharma Inc Stock (ABVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):